phorbolol myristate acetate has been researched along with diclofenac in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan, M; Çeker, T; Köksoy, S; Yilmaz, Ç | 1 |
1 other study(ies) available for phorbolol myristate acetate and diclofenac
| Article | Year |
|---|---|
Diclofenac down-regulates COX-2 induced expression of CD44 and ICAM-1 in human HT29 colorectal cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Survival; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diclofenac; Down-Regulation; Gene Expression Regulation, Neoplastic; HCT116 Cells; HT29 Cells; Humans; Hyaluronan Receptors; Intercellular Adhesion Molecule-1; Tetradecanoylphorbol Acetate | 2021 |